Skip to Content
 

News: Research

Evading cell death

Monday, November 12th, 2018

A recent study reveals how cellular structures called ‘stress granules’ help cells evade death. The findings may lead to new strategies for improving the efficacy of cancer therapy.

Team’s findings show glutamine metabolism affects T cell signaling

Monday, November 5th, 2018

A drug currently in clinical trials as an anticancer agent might also be useful as a treatment for inflammatory and autoimmune diseases. The findings also suggests strategies for using the drug to enhance cancer immunotherapies.

Clues to bone metastases

Monday, November 5th, 2018

A recent study by Rachelle Johnson, Ph.D., and colleagues looked at factors influencing the ability of breast cancer cells to colonize bone and enter and exit a dormant state.

Combination therapy improves small-cell lung cancer survival

Friday, October 26th, 2018

Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.

Studying cellular deliveries

Friday, October 26th, 2018

In an article recently published in Cell Reports, James G. Patton, PhD, and colleagues studied how colon cancer cells can secrete long RNAs in carefully regulated ways.

Mary Kay Foundation grant to bolster immunotherapy research

Monday, October 22nd, 2018

Charles Caskey, Ph.D., has received a cancer research grant from The Mary Kay Foundation to study how focused ultrasound therapy could be an ideal helper for immunotherapy.

MIT’s Amon named to receive Vanderbilt Prize

Monday, October 22nd, 2018

Angelika Amon, PhD, whose groundbreaking investigations of chromosome segregation during cell division have advanced understanding of how cancer may develop, is the recipient of the 2018 Vanderbilt Prize in Biomedical Science.

Grant enhances study of new chemotherapy targets

Monday, October 22nd, 2018

Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Predators’ gift bolsters fight against pediatric cancer

Monday, October 22nd, 2018

Nashville Predators goaltender Pekka Rinne, Predators executives and executives from Tri Star Energy (Twice Daily) made their annual presentation recently of proceeds from the team’s 365 Pediatric Cancer Fund to Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Cancer Center investigators awarded Komen grants

Friday, October 12th, 2018

Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

Next Page »